Discuss This Drug

Orphenadrine

CHEBI:CHEBI_7789

Definition

A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.

Chemical Information

Molecular Formula
C18H23NO
Molecular Mass
269.38130
Charge
0
SMILES
CN(C)CCOC(c1ccccc1)c1ccccc1C
InChI
InChI=1S/C18H23NO/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16/h4-12,18H,13-14H2,1-3H3
InChIKey
QVYRGXJJSLMXQH-UHFFFAOYSA-N

Alternative Names

  • 2-(phenyl-o-tolylmethoxy)ethyldimethylamine
  • 2-methyldiphenhydramine
  • beta-dimethylaminoethyl 2-methylbenzhydryl ether
  • Dimethyl-[2-(phenyl-o-tolyl-methoxy)-ethyl]-amine
  • N,N-dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine
  • N,N-dimethyl-2-(phenyl(o-tolyl)methoxy)ethanamine
  • N,N-dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethanamine
  • N,N-dimethyl-2-[(o-methyl-alpha-phenylbenzyl)oxy]ethylamine
  • o-methyldiphenhydramine
  • o-monomethyldiphenhydramine
  • orfenadrina
  • orphenadrine
  • Orphenadrine
  • ORPHENADRINE
  • orphenadrinum
  • phenyl-o-tolylmethyl dimethyaminoethyl ether

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

core#notation
CHEBI:7789
DRON_00010000
7715
oboInOwl#hasDbXref
Wikipedia:Orphenadrine

Additional References

Wikipedia:Orphenadrine

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

package_description
1 kg in 1 BOTTLE (51927-0245-0)
package_ndc
38779-0452-2
manufacturer_name
Galt Pharmaceuticals, LLC
package_marketing_start_date
02-SEP-22
core#notation
CHEBI:7789
product_type
BULK INGREDIENT
listing_expiration_date
20241231
route
INTRAVENOUS
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
labeler_name
Galt Pharmaceuticals, LLC
marketing_start_date
20030428
application_number
ANDA075141
spl_id
0e9b5f79-80d7-fccd-e063-6394a90af1fa
dosage_form
TABLET, EXTENDED RELEASE
oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
7715
oboInOwl#hasDbXref
Wikipedia:Orphenadrine
oboInOwl#hasAlternativeId
CHEBI:177779
oboInOwl#id
CHEBI:7789
generic_name
Orphenadrine Citrate, Aspirin and Caffeine
brand_name
ORPHENGESIC FORTE
brand_name_base
ORPHENGESIC FORTE
product_ndc
51927-0245
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_37955
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
active_ingredient_name
ORPHENADRINE CITRATE
rxcui
994539
pharm_class
Decreased Platelet Aggregation [PE]
active_ingredient_strength
385 mg/1
nui
N0000008832
pharm_class_epc
Platelet Aggregation Inhibitor [EPC]
pharm_class_moa
Cyclooxygenase Inhibitors [MoA]
pharm_class_cs
Xanthines [CS]
unii
X0A40N8I4S
pharm_class_pe
Decreased Platelet Aggregation [PE]
spl_set_id
ed406e8a-ec00-4711-ae2b-3c5af4f15438
upc
0367296070910
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect34931
owl#annotatedSource
t297224
owl#someValuesFrom
t3000765
has_treatment
http://purl.obolibrary.org/obo/DOID_0060367